Annals of Coloproctology

Original Article

Colorectal cancer

Lymphovascular invasion in colorectal cancers: can we predict it preoperatively?: Elbrus Zarbaliyev, Nihan Turhan, Sebahattin Çelik, Mehmet Çağlıkülekçi; Ann Coloproctol. 2024;40(3):245-252. Published online June 25, 2024; DOI: https://doi.org/10.3393/ac.2023.00458.0065

2,435 View
179 Download

Abstract PDF: Purpose
This study aimed to investigate preoperative predictors of lymphovascular invasion (LVI), which is a poor prognostic factor usually detected postoperatively in patients with colorectal cancer.
Methods
Results for all patients operated on for colorectal cancer between January 1, 2006, and December 31, 2021, were retrospectively analyzed. Potential preoperative factors and postoperative pathology results were recorded. The patients were categorized as those with LVI and those without LVI. Potential factors that may be associated with LVI were compared between the 2 groups.
Results
The study included 335 patients. The incidence of LVI was 3.11 times higher in patients with ascending colon tumors (odds ratio [OR], 3.11; 95% confidence interval [CI], 1.34–7.23; P=0.008) and 4.28 times higher in those with metastatic tumors (OR, 4.28; 95% CI, 2.18–8.39; P<0.001). Diabetes mellitus was inversely related to LVI in colorectal cancer patients; specifically, LVI was 56% less common in colorectal cancer patients with diabetes mellitus, irrespective of its duration (OR, 0.44; 95% CI, 0.25–0.76; P<0.001).
Conclusion
The presence of preoperative LVI in colorectal cancer patients is difficult to predict. In particular, the effect of the effect of factors such as chronic disease accompanied by microvascular pathologies on LVI is still unclear. Advances in the neoadjuvant treatment of colorectal cancer patients, who are becoming more widespread every day, will encourage the investigation of different methods of preoperatively predicting LVI as a poor prognostic factor in these patients.

Case Reports

Multivisceral resection for colonic splenic flexure malakoplakia: a case report of a minimally invasive approach: Andrés Ramiro Lanza Díaz, Santiago Gallardo Pezet, Osvaldo Soto González, Montserrat Guraieb Trueba, Ivan Azael Martínez Alonso, Mario Alberto López Ramirez; Ann Coloproctol. 2023;39(2):178-182. Published online July 21, 2021; DOI: https://doi.org/10.3393/ac.2021.00178.0025

4,272 View
146 Download
1 Web of Science
1 Citations

Abstract PDF

Malakoplakia is a rare granulomatous inflammatory disorder. Its diagnosis depends on histopathological findings; however, high-quality literature regarding proper medical/surgical treatment is lacking. A 38-year-old diabetic female patient was admitted to the emergency room with a history of lower gastrointestinal hemorrhage. Colonoscopy revealed a lesion in the descending colon, and abdominal computed tomography revealed a splenic flexure mass involving the lower pole of the spleen and upper pole of the left kidney. Biopsies confirmed the diagnosis of malakoplakia. After completing antibiotic treatment, a restaging computed tomography revealed a discrete mass increase; hence, the patient underwent laparoscopic en bloc colectomy and partial nephrectomy. Postoperatively, the patient developed a pancreatic fistula, which was successfully treated with percutaneous drainage and antibiotics. The presence of pathognomonic Michaelis-Gutmann inclusions on histopathology is frequently reported as the key to diagnosing malakoplakia. Herein, we present a successful, minimally invasive surgical treatment for colonic malakoplakia.

Citations

Citations to this article as recorded by

A Surgical Challenge Generated by Colonic Malakoplakia in Disguise as a Locally Advanced Colonic Malignancy—A Case Report
Cristina Șerban, Alexandra Toma, Dragoș Cristian Voicu, Constantin Popazu, Dorel Firescu, George Țocu, Raul Mihailov, Laura Rebegea
Medicina.2023; 59(1): 156. CrossRef

Benign proctology,Rare disease & stoma,Complication

Fournier Gangrene in a Patient With Type 2 Diabetes Mellitus Treated With Dapagliflozin: A Case Report: Jae Young Moon, Min Ro Lee, Jong Hun Kim, Gi Won Ha; Ann Coloproctol. 2021;37(Suppl 1):S48-S50. Published online May 28, 2021; DOI: https://doi.org/10.3393/ac.2020.06.22

5,118 View
157 Download
5 Web of Science
7 Citations

Abstract PDF

Rare cases of Fournier gangrene (FG) possibly associated with sodium-glucose cotransporter 2 inhibitors have been reported. We present a case of a 66-year-old male patient with type 2 diabetes mellitus on oral metformin, glimepiride, and dapagliflozin therapy. He presented with pain in the perineum and scrotum for 5 days. The clinical finding, computed tomography finding, and laboratory data were matched with FG. Emergency surgical drainage, debridement of necrotic tissue, and diverting loop ileostomy formation were performed by a urologist and a surgeon. The patient had no complications from diabetes before the onset of FG, and serum glucose management was good at the onset of FG. This case shows an FG patient with good glucose management taking dapagliflozin and suggests a possible association between dapagliflozin and FG. Further evaluation and additional research on this relationship are needed.

Citations

Citations to this article as recorded by

Cost-effectiveness analysis and medication use for gangrene treatment in type 2 diabetes patients: A systematic literature review
Entris Sutrisno, Jajang Japar Sodik, Taufik Muhammad Fakih
Pharmacia.2025; 72: 1. CrossRef
Fournier’s Gangrene as an Adverse Event Following Treatment with Sodium Glucose Cotransporter 2 Inhibitors
Ioana-Maria Suciu, Alin Greluș, Alina-Ramona Cozlac, Bogdan-Simion Suciu, Svetlana Stoica, Silvia Luca, Constantin-Tudor Luca, Dan-Ion Gaiță
Medicina.2024; 60(5): 837. CrossRef
A Case of Fournier's Gangrene Following the Initiation of Dapagliflozin
Natalie Shaykh, Avni Agrawal, Melville C O'Brien, Oshin Rai, Vanshika Tripathi, Vishal Jaikaransingh
Cureus.2024;[Epub] CrossRef
Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs—A Review of Literature and Case Reports
Justyna Kowalska, Dorota Wrześniok
Pharmaceuticals.2024; 17(7): 847. CrossRef
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors
Alexandra Laura Mederle, Patrick Dumitrescu, Claudia Borza, Nilima Rajpal Kundnani
Journal of Clinical Medicine.2024; 14(1): 188. CrossRef
Management of Fournier’s gangrene during the Covid-19 pandemic era: make a virtue out of necessity
Alessio Paladini, Giovanni Cochetti, Angelica Tancredi, Matteo Mearini, Andrea Vitale, Francesca Pastore, Paolo Mangione, Ettore Mearini
Basic and Clinical Andrology.2022;[Epub] CrossRef
Dapagliflozin

Reactions Weekly.2022; 1926(1): 197. CrossRef

Original Article

Effect of Diabetes Mellitus on Outcomes of Colorectal Cancer: Geum Youb Noh, Dae-Yong Hwang, Yoon Hee Choi, Yun Yong Lee; J Korean Soc Coloproctol. 2010;26(6):424-428. Published online December 31, 2010; DOI: https://doi.org/10.3393/jksc.2010.26.6.424

4,602 View
26 Download
25 Citations

Abstract PDF

Purpose

Many studies have revealed that diabetes mellitus (DM) increases a person's lifetime risk of colorectal cancer and that DM is associated with a worse outcome of colon cancer, but this association is controversial. In this study, we intended to examine the relationship between DM and the long-term outcomes of colorectal cancer.

Methods

A retrospective analysis was conducted on 657 patients who underwent surgery due to colorectal cancer between 1997 and 2004 at Korea Cancer Center Hospital. The operations were done by a single surgeon. With a median follow-up of 4.7 years, we analyzed differences in recurrence-free survival (RFS) and overall survival (OS) between patients with DM and those without DM.

Results

Of the 657 patients, 374 (57%) were males and 67 (10%) had DM. There was no difference in age at diagnosis, sex and pathologic stage of colorectal cancer according to the presence of DM. There were no difference in the RFS and the OS of colon cancer between the patients with DM and those without DM. At 5 years, the RFS was 71.3% in diabetic patients vs. 70.4% in non-diabetic patients (P = 0.480), and the OS was 68.8% in diabetic patients vs. 75.0% in non-diabetic patients (P = 0.498). There was no difference in the median survival between the groups (9.6 years in the diabetic group vs. 10.6 years in the non-diabetic group; P = 0.495).

Conclusion

In this study, we did not find any relation between the presence of DM and either the recurrence or the survival in cases of colorectal cancer. More studies to elucidate whether the influence of DM is directly related to a higher rate of cancer recurrence or survival are needed.

Citations

Citations to this article as recorded by

Diabetes and cancer: Optimising glycaemic control
Nalinie Joharatnam‐Hogan, Daniel L. Morganstein
Journal of Human Nutrition and Dietetics.2023; 36(2): 504. CrossRef
The impact of the incidence of diabetic complications on mortality in colorectal cancer patients with diabetes: A nationwide study
Woo-Ri Lee, Kyu-Tae Han, Yoon Jung Chang, Seojin Park, Woorim Kim
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Effect of diabetes mellitus comorbidity on outcomes in stages II and III colorectal cancer
Cheng‐Yao Lin, Chien‐Liang Lin, Wen‐Tsung Huang, Cheau‐Jane Peng, Shih‐Bin Su, How‐Ran Guo
Asia-Pacific Journal of Clinical Oncology.2022;[Epub] CrossRef
Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer
Jan Dimberg, Levar Shamoun, Kalle Landerholm, Dick Wågsäter
World Journal of Gastroenterology.2022; 28(19): 2148. CrossRef
Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis
Daniel J. Becker, Arjun D. Iyengar, Salman R. Punekar, Dalia Kaakour, Megan Griffin, Joseph Nicholson, Heather T. Gold
International Journal of Colorectal Disease.2020; 35(11): 1989. CrossRef
Socioclinical profile of patients seeking treatment for cancer in a Teaching hospital in east Delhi, India
Utsav Gupta, MadhuKumari Upadhyay, Rahul Sharma
Journal of Family Medicine and Primary Care.2020; 9(6): 2763. CrossRef
Postoperative serum carcinoembryonic antigen levels cannot predict survival in colorectal cancer patients with type II diabetes
Chih-Sheng Huang, Chin-Yau Chen, Li-Kuo Huang, Wei-Shu Wang, Shung-Haur Yang
Journal of the Chinese Medical Association.2020; 83(10): 911. CrossRef
Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 Diabetes in the Etiology of Colon Cancer
Wedad Saeed Al-Qahtani, Ebtesam Al-Olayan, Fatimah Gh. Albani, Rania Saad Suliman, Nada Hamad Aljarba, E.M. Al-Humaidhi, Alanood S. Almurshedi, Dalia Mostafa Domiaty, Manal Abdullah Alduwish, Aljohara M. Al-Otaibi, Abdelbaset Mohamed Elasbali, Hussain Gad
Global Medical Genetics.2020; 07(02): 035. CrossRef
Survival and Glycemic Control in Patients With Colorectal Cancer and Diabetes Mellitus
Nina J Karlin, Shailja B Amin, Heidi E Kosiorek, Matthew R Buras, Patricia M Verona, Curtiss B Cook
Future Science OA.2018;[Epub] CrossRef
Risk of colon cancer recurrence in relation to diabetes
Jessica Chubak, Onchee Yu, Rebecca A. Ziebell, Erin J. Aiello Bowles, Andrew T. Sterrett, Monica M. Fujii, Jennifer M. Boggs, Andrea N. Burnett-Hartman, Denise M. Boudreau, Lu Chen, James S. Floyd, Debra P. Ritzwoller, Rebecca A. Hubbard
Cancer Causes & Control.2018; 29(11): 1093. CrossRef
High glucose induces epithelial‑mesenchymal transition and results in the migration and invasion of colorectal cancer cells
Jiayan Wu, Jiayi Chen, Yang Xi, Fuyan Wang, Hongcun Sha, Lin Luo, Yabin Zhu, Xiaoming Hong, Shizhong Bu
Experimental and Therapeutic Medicine.2018;[Epub] CrossRef
Optimal glycemic target level for colon cancer patients with diabetes
Shin Jun Lee, Jae Hyun Kim, Seun Ja Park, So Young Ock, Su Kyoung Kwon, Young Sik Choi, Bu Kyung Kim
Diabetes Research and Clinical Practice.2017; 124: 66. CrossRef
The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies
Bo Zhu, Xiaomei Wu, Bo Wu, Dan Pei, Lu Zhang, Lixuan Wei, Masaru Katoh
PLOS ONE.2017; 12(4): e0176068. CrossRef
Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
Jingtao Li, Jixi Liu, Chun Gao, Fang Liu, Hongchuan Zhao
Oncotarget.2017; 8(37): 62478. CrossRef
Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran
Mohammad Aziz Rasouli, Ghobad Moradi, Daem Roshani, Bahram Nikkhoo, Ebrahim Ghaderi, Bahman Ghaytasi
Medicine.2017; 96(6): e5941. CrossRef
Impact of Hyperglycemia on Survival and Infection-Related Adverse Events in Patients with Metastatic Colorectal Cancer Who Were Receiving Palliative Chemotherapy
Yong Joo Hong, Hye-Suk Han, Yusook Jeong, Jiwon Jeong, Sung-Nam Lim, Hyung Jin Choi, Hyun-Jung Jeon, Tae-Keun Oh, Sang-Jeon Lee, Ki Hyeong Lee
Cancer Research and Treatment.2014; 46(3): 288. CrossRef
High Glucose Modulates Antiproliferative Effect and Cytotoxicity of 5-Fluorouracil in Human Colon Cancer Cells
Yi-Shing Ma, I-Ping Yang, Hsiang-Lin Tsai, Ching-Wen Huang, Suh-Hang Hank Juo, Jaw-Yuan Wang
DNA and Cell Biology.2014; 33(2): 64. CrossRef
Diabetes and prognosis in older persons with colorectal cancer
J Luo, H-C Lin, K He, M Hendryx
British Journal of Cancer.2014; 110(7): 1847. CrossRef
Type 2 Diabetes Mellitus Is Associated With Increased Mortality in Chinese Patients Receiving Curative Surgery for Colon Cancer
Kuo-Hsing Chen, Yu-Yun Shao, Zhong-Zhe Lin, Yi-Chun Yeh, Wen-Yi Shau, Raymond Nienchen Kuo, Ho-Min Chen, Chiu-Ling Lai, Kun-Huei Yeh, Ann-Lii Cheng, Mei-Shu Lai
The Oncologist.2014; 19(9): 951. CrossRef
Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer
Justin Y. Jeon, Duck Hyoun Jeong, Min Geun Park, Ji-Won Lee, Sang Hui Chu, Ji-Hye Park, Mi Kyung Lee, Kaori Sato, Jennifer A. Ligibel, Jeffrey A. Meyerhardt, Nam Kyu Kim, Antonio Moschetta
PLoS ONE.2013; 8(2): e55196. CrossRef
Diabetes Mellitus and Colorectal Cancer Prognosis
Katherine T. Mills, Charles F. Bellows, Aaron E. Hoffman, Tanika N. Kelly, Giuseppe Gagliardi
Diseases of the Colon & Rectum.2013; 56(11): 1304. CrossRef
The Role of Diabetes and Diabetes Treatments in Colorectal Cancer Mortality, Incidence, and Survival
Peter T. Campbell
Current Nutrition Reports.2013; 2(1): 37. CrossRef
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study
Alessandro Antonelli, Nicola Arrighi, Serena Corti, Tiziano Zanotelli, Alberto Cozzoli, Sergio Cosciani Cunico, Claudio Simeone
Urologic Oncology: Seminars and Original Investigations.2013; 31(7): 1310. CrossRef
The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
Ching-Wen Huang, Li-Chu Sun, Ying-Ling Shih, Hsiang-Lin Tsai, Chao-Wen Chen, Yung-Sung Yeh, Cheng-Jen Ma, Che-Jen Huang, Jaw-Yuan Wang
World Journal of Surgical Oncology.2012;[Epub] CrossRef
The Association between Obesity and Colorectal Cancer
Kevin Whitlock, Richdeep S. Gill, Daniel W. Birch, Shahzeer Karmali
Gastroenterology Research and Practice.2012; 2012: 1. CrossRef

First
Prev
Page of 1
Next
Last

Search